about
Fluoxetine for adult overweight or obese peopleOmental adipose tissue gene expression, gene variants, branched-chain amino acids, and their relationship with metabolic syndrome and insulin resistance in humans.Metadoxine improves the three- and six-month survival rates in patients with severe alcoholic hepatitis.Bone mineral density after bariatric surgery. A systematic review.Review of complementary feeding practices in Mexican children.Enteral nutritional support in non-ICU hospitalized patients: current practice in Mexico.Clinical classification of adult patients with chronic intestinal failure due to benign disease: An international multicenter cross-sectional survey.Validating an energy expenditure prediction equation in overweight and obese Mexican patients.Validation of a new formula for predicting body weight in a Mexican population with overweight and obesity.Increased Efficacy and Safety of Enteral Nutrition Support with a Protocol (ASNET) in Noncritical Patients: A Randomized Controlled Trial.The two sides of superior mesenteric artery syndrome treatment: conservative or surgical management?Medical and nutritional treatment in adult patients with acute intestinal failure[Nutritional assessment of alcoholic liver cirrhotic patients treated in the liver Clinic of the Mexico's General Hospital][Sarcopenia and functionality in elderly inpatient]Accurate determination of energy requirements in hospitalised patients with parenteral nutritionValidation and Adaptation of the Spanish Version of the STRONGkids Nutrition Screening Tool
P50
Q24188314-0BB08ADA-E34F-4CB4-B7F0-701E53DA5256Q34252080-36DE41BE-B8E0-49FA-932E-4DB4D4CD0FFBQ35534087-9DBB2BEF-582B-4CC0-AEA0-08EACFFAC03AQ38238734-7C1B8719-38C6-4992-A71F-83A4065A1A28Q38330789-6C086A46-FB87-4411-9FE1-EB928072BF91Q38743034-685E54EC-508D-4A2B-B98F-0C3E3849BE63Q38797361-8B55565D-47E7-4D03-B63B-9E69B31A5956Q39109764-1B010A55-8854-44BF-9098-39BB6E1C275BQ39386009-F689BCBA-ED18-48CB-8BBC-4E04C8708750Q47258284-5D08C37D-FF72-48AC-93E6-482BC3E79231Q47592393-1735BFCF-F2DB-4454-8025-EEFDF3BE097CQ58587838-71E3BC77-AD32-426A-BEE3-C110FB9EDBACQ86599399-F10FA624-67D4-4840-ACFE-562E825D7DD0Q86969480-DF5339C8-71D1-4F34-9126-84A97B1247F3Q88622907-46A6D9EF-58E6-4992-87C3-F0AE5A7C3565Q90713105-00126556-EAB7-4CC2-A0F6-E6C2D4639257
P50
description
researcher ORCID ID = 0000-0001-5579-1450
@en
wetenschapper
@nl
name
Aurora E Serralde-Zúñiga
@ast
Aurora E Serralde-Zúñiga
@en
Aurora E Serralde-Zúñiga
@es
Aurora E Serralde-Zúñiga
@nl
type
label
Aurora E Serralde-Zúñiga
@ast
Aurora E Serralde-Zúñiga
@en
Aurora E Serralde-Zúñiga
@es
Aurora E Serralde-Zúñiga
@nl
prefLabel
Aurora E Serralde-Zúñiga
@ast
Aurora E Serralde-Zúñiga
@en
Aurora E Serralde-Zúñiga
@es
Aurora E Serralde-Zúñiga
@nl
P1153
57201842962
P21
P31
P496
0000-0001-5579-1450